While stem cell therapy has traditionally centered on mesenchymal stem cells (MSCs), MUSE cells are quickly gaining traction ...

The promise of stem cell therapy is powerful. Scientists can draw versatile cells from the human body and deliver them to ...

Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

Findings from two studies reveal advancements in stem cell-derived treatment options to treat type 1 diabetes. Results from the FORWARD study, also simultaneously published in the New England Journal ...

are worried that the FDA may loosen oversight on stem cell therapy, which could confuse the public about the difference between scientifically supported treatment and untested therapies. Their ...

Medicare covers FDA-approved stem cell therapies specifically for bleeding disorders and certain cancers. However, out-of-pocket costs can still be high even with Medicare Advantage (Part C ...

Stem cells can fight disease from the inside out ... Their concerns come in part from Health Secretary Robert F. Kennedy Jr.’s remarks on the subject, including a post on X in October calling ...

Mesenchymal stem cells (MSCs), which can be harvested from fat and bone marrow, have immune-modulating and anti-inflammatory ...